2082 related articles for article (PubMed ID: 8923836)
1. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
[TBL] [Abstract][Full Text] [Related]
3. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
4. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
Kriström B; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Sep; 82(9):2889-98. PubMed ID: 9284715
[TBL] [Abstract][Full Text] [Related]
5. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
[TBL] [Abstract][Full Text] [Related]
6. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children.
Boguszewski M; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1995 Sep; 80(9):2599-606. PubMed ID: 7673401
[TBL] [Abstract][Full Text] [Related]
8. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
[TBL] [Abstract][Full Text] [Related]
9. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Dahlgren J; Bjarnason R; Rosberg S; Carlsson LM; Carlsson B; Albertsson-Wikland K
Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
[TBL] [Abstract][Full Text] [Related]
10. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment.
de Ridder MA; Stijnen T; Hokken-Koelega AC
J Clin Endocrinol Metab; 2008 Feb; 93(2):477-83. PubMed ID: 18000093
[TBL] [Abstract][Full Text] [Related]
11. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
[TBL] [Abstract][Full Text] [Related]
12. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
[TBL] [Abstract][Full Text] [Related]
13. High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.
van Dijk M; Mulder P; Houdijk M; Mulder J; Noordam K; Odink RJ; Rongen-Westerlaken C; Voorhoeve P; Waelkens J; Stokvis-Brantsma J; Hokken-Koelega A
J Clin Endocrinol Metab; 2006 Apr; 91(4):1390-6. PubMed ID: 16464954
[TBL] [Abstract][Full Text] [Related]
14. The endocrine phenotype in silver-russell syndrome is defined by the underlying epigenetic alteration.
Binder G; Seidel AK; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Eggermann T; Ranke MB
J Clin Endocrinol Metab; 2008 Apr; 93(4):1402-7. PubMed ID: 18230663
[TBL] [Abstract][Full Text] [Related]
15. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
16. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
Binder G; Baur F; Schweizer R; Ranke MB
J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
[TBL] [Abstract][Full Text] [Related]
17. Reduced levels of GH during GnRH analogue treatment in pubertal short girls born small for gestational age (SGA).
van der Kaay DC; Rose SR; van Dijk M; Noordam C; van Rheenen E; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2009 Jun; 70(6):914-9. PubMed ID: 19178519
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
van der Kaay DC; Hendriks AE; Ester WA; Leunissen RW; Willemsen RH; de Kort SW; Paquette JR; Hokken-Koelega AC; Deal CL
Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate and the response to growth hormone treatment in short children born small for gestational age.
Renes JS; de Ridder MA; Breukhoven PE; Lem AJ; Hokken-Koelega AC
PLoS One; 2012; 7(12):e53164. PubMed ID: 23300884
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
